Research on inflammatory disease widens

Research on inflammatory disease widens
Research on inflammatory disease widens

Hello and welcome to the details of Research on inflammatory disease widens and now with the details

Nevin Al Sukari - Abu Dhabi - Photo has been used for illustrative purposes.

Mariecar Jara-Puyod, Senior Reporter

An epidemiological study of Inflammatory Bowel Diseases (IBD) is being scheduled in Abu Dhabi as everyone has yet to fully understand the mystery of these set of conditions, which, among its complications, if undiagnosed or misdiagnosed is colorectal cancer.

“If all goes as planned, we will expand this venture further to include the entire country,” Dr. Talha Aziz Malik told Gulf Today recently, adding that while many inconsistencies in collated studies have to be corrected, IBD rates in other parts of the globe, other than among the Caucasians in North America, Europe and Australia, have spiked tremendously.

“Epidemiological studies allow us to understand occurrence, distribution and risk factors of a certain disease in a certain area and represent a first key step to helping prevent when possible and managing that disease,” the Internal Medicine and Gastroenterology specialist/assistant professor affiliated with the USA-headquartered Mayo Clinic, UAB Highlands Hospital and Alabama University Hospital.

On Monday, Malik was announced as the new Sheikh Shakhbout Medical Centre (SSMC) IBD Centre director. SSMC is a joint venture partnership of the Abu Dhabi Health Services Company and Mayo Clinic. Its IBD Centre will pursue the comprehensive patient-centred approach wherein among the multidisciplinary team of medical practitioners are colorectal surgeons as well as experts in chromosome colonoscopy and chromoendoscopy.

Malik mentioned the Abu Dhabi IBD research study when interviewed in connection with the annual May 19 “World IBD Day.” Like former Emirates Gastroenterology and Hepatology Society president Dr. Maryam Al Khatry, founder/president of the recently launched patient-focused UAE IBD Society, Malik pointed out the absence of a well-conceptualised national registry and the serious need for in-depth research works: “There has not been any sound epidemiological data published for IBD in the UAE thus far. We know however that in general, IBD epidemiological data from Africa and the Middle East reveal similar trends to that in North America. We will start off with our patients (at SSMC) then expand the research to include other Abu Dhabi residents.” Malik with 22 years of work experience, said the SSMC-initiated Abu Dhabi IBD Epidemiological Study will help clarify many inconsistent conclusions: “We actually do not know the cause of IBD. What we do know is that IBD describes two disease entities: Crohn’s Disease (CD) and Ulcerative Colitis. These result from an uncontrolled immune-mediated inflammatory response in genetically-pre-disposed individuals to a still unknown environmental trigger that interacts with the intestinal flora and primary affects the gastrointestinal tract.”

These were the details of the news Research on inflammatory disease widens for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Gulf Today and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV UAE residents urged to take COVID-19 booster vaccine dose after 6 months of the second dose
NEXT Sheikh Mohammed issues decrees on boards of various entities